Monitoring algorithm of hospitalized patients in a medical center with SARS-CoV-2 (Omicron variant) infection: clinical epidemiological surveillance and immunological assessment
Purpose Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major healthcare threat worldwide. Since it was first identified in November 2021, the Omicron (B.1.1.529) variant of SARS-CoV-2 has evolved into several lineages, including BA.1...
Main Authors: | Chi-Sheng Chen, Ming-Jr Jian, Chih-Kai Chang, Hsing-Yi Chung, Shih-Yi Li, Jung-Chung Lin, Kuo-Ming Yeh, Ya-Sung Yang, Chien-Wen Chen, Shan-Shan Hsieh, Sheng-Hui Tang, Cherng-Lih Perng, Feng-Yee Chang, Hung-Sheng Shang |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/14666.pdf |
Similar Items
-
The latest Omicron BA.4 and BA.5 lineages are frowning toward COVID‐19 preventive measures: A threat to global public health
by: Md. Rabiul Islam, et al.
Published: (2022-11-01) -
Immunological and Molecular Diagnosis of Cytomegalovirus Infection between Aborted & Pregnant Women in Babylon City
by: Haider Turky Mousa Al-Mousawi, et al.
Published: (2021-06-01) -
Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity
by: Marija Vukčević, et al.
Published: (2024-01-01) -
Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China
by: Xiaofeng He, et al.
Published: (2024-01-01) -
SARS-CoV-2 Antinucleocapsid Antibody Response of mRNA and Inactivated Virus Vaccines Compared to Unvaccinated Individuals
by: Arwa Qaqish, et al.
Published: (2022-04-01)